C Mennan, J Garcia, S Roberts, C Hulme… - Stem cell research & …, 2019 - Springer
Background The manufacture of mesenchymal stem/stromal cells (MSCs) for clinical use needs to be cost effective, safe and scaled up. Current methods of expansion on tissue …
F Syed, R El Fakih, AD Alahmari, ASO Ali… - … /Oncology and Stem …, 2022 - journals.lww.com
Increasing success of adaptive cell therapy (ACT), such as genetically engineered T cells to express chimeric antigen receptors (CARs) proven to be highly significant technological …
CH Hulme, C Mennan, HS McCarthy, R Davies, T Lan… - Cytotherapy, 2023 - Elsevier
The Quantum cell expansion system manufactured by Terumo-BCT is perhaps the most widely reported Good Manufacturing Practice–compliant bioreactor used for the expansion …
ND Frank, E Zylberberg, MB Roufai, SL Gibb, MM Miller - Cytotherapy, 2024 - Elsevier
Background aims The need for large-scale production of mesenchymal stromal cell (MSC)- based cellular therapeutics continues to grow around the globe. Manual cell expansion …
J Hoover, PJ Hanley - A Roadmap to Non-Hematopoietic Stem Cell-based …, 2019 - Elsevier
Establishing a master cell bank requires compliance with the federal regulations. These regulations work to ensure the quality, safety, and efficacy of the finished product …
P O'heeron, T Ichim - US Patent App. 17/310,007, 2022 - Google Patents
BACKGROUND [0003] Regenerative medicine, applied in the form of stem cell therapy, offers the possibility of treating many previ ously incurable diseases. Numerous types of …